A subsidiary of a South Korea-based biotechnology firm has opened a new state-of-the-art facility in Abingdon.
MediMab Biotherapeutics, a subsidiary of MediMabBio, has launched its new facility at Sovereign House, Abingdon Science Park.
Developed by Kadans Science Partner, the purpose-built building incudes CL2 wet labs, used for work with medium risk hazards, aimed at supporting the company's accelerated growth and development in immuno-oncology therapeutics.
The company is moving from The BioEscalator in Oxford where it has previously operated from.
MediMab Biotherapeutics’ discovery platform uses advances in systems biology combined with immunological solutions to identify significantly improved immuno-oncology drugs, those which affect immune systems, that can actively target a range of advanced and solid tumours.
The company was founded in 2020 by Dr Ji Eun Lee with the goal to develop MediMabBio's work with the Oxford University Hospital to do research on the development of new immuno-oncology drugs, alongside strengthening the network with local biopharmaceutical companies.
Dr Ji Eun Lee, CEO MediMab Biotherapeutics, said: "The new state-of-the-art facilities delivered by Kadans Science Partner will help MediMab Biotherapeutics to transform the cancer treatment landscape through groundbreaking developments of protein therapeutics, including therapeutic antibodies and fusion proteins.
"Kadans has provided us with the very best environment to work, and we are proud to be within one of the UK’s most prestigious science parks."
Katie Nelson, head of leasing UK and Ireland, Kadans Science Partner, added: “We are delighted to add another internationally based company to our newly refurbished Sovereign House where MediMab Biotherapeutics will join our collective of great scientific businesses at Abingdon Science Park.
"It has been a pleasure to work closely with MediMab to provide them with a bespoke laboratory solution that aligns with their future business plan. We wish them every success with their new move and are proud to welcome them to our UK ecosystem."
Abingdon Science Park is a leading life-science research park spanning more than 500,000 sq ft, and is home to companies such as Genefirst, Sherlock Biosciences, Akamis Bio, Penlon, Scilogica and Oxdevice.
MediMab Biotherapeutics will join Helix Geospace who moved to Sovereign House in January.
Kadans Science Partner has recently completed Barton House at Abingdon Science Park. The building is around 25,000 sq.ft of laboratory space and houses an onsite cafe that can be used by all of the park occupiers.
There is now a shuttle bus service between Didcot Parkway to Abingdon Science Park that is available to all Kadans Science Partner occupiers.
Properties on the park are jointly leased by specialised science and technology advisors DTRE and Bidwells.
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules here